+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Contrast Media Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6083676
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Contrast Media Market is projected to reach USD 7.64 Billion in 2026. It is expected to continue growing at a CAGR of 8.26%, reaching USD 12.35 Billion by 2032.

Contrast media are indispensable to modern diagnostic imaging, improving the visibility of blood vessels, organs, soft tissues, and gastrointestinal structures across CT, MRI, ultrasound, fluoroscopy, and interventional radiology. Demand is supported by the documented global burden of cardiovascular disease, cancer, neurological disorders, trauma, and chronic kidney disease, all of which rely on high-quality imaging for diagnosis, treatment planning, and follow-up.

The contrast media landscape is shaped by four core product families: iodinated contrast media for CT and angiography, gadolinium-based contrast agents for MRI, microbubble agents for contrast-enhanced ultrasound, and barium-based agents for gastrointestinal studies. Adoption is increasingly linked to safer formulations, automated injectors, protocol standardization, and imaging workflows that reduce dose, waste, and adverse-event risk while preserving diagnostic confidence.

Transformative Shifts in the Contrast Media Landscape

The contrast media landscape is shifting from volume-driven use toward precision, safety, and workflow efficiency. Radiology departments are prioritizing low-osmolar and iso-osmolar iodinated agents, macrocyclic gadolinium agents, and ultrasound contrast where clinically appropriate, reflecting guidance from organizations such as the American College of Radiology and the European Society of Urogenital Radiology.

Healthcare systems are also moving toward protocol-based procurement, centralized contrast management, and integrated injector platforms. Hospitals are responding to documented supply-chain disruptions by diversifying qualified suppliers, building inventory resilience, monitoring expiration risk, and using dose optimization to protect access during shortages without compromising diagnostic quality.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across the contrast media value chain. In clinical imaging, AI-enabled reconstruction, segmentation, workflow orchestration, and protocol selection can help radiology teams maintain image quality while reducing contrast dose, repeat scans, and scan time. AI tools also support patient stratification by identifying risk factors such as impaired renal function, prior hypersensitivity reactions, medication interactions, and repeat imaging exposure.

For manufacturers and providers, AI improves demand planning, inventory control, adverse-event monitoring, injector utilization analytics, and post-market signal detection. Adoption must remain aligned with FDA and EU software-as-a-medical-device expectations, cybersecurity controls, data governance, and validated clinical evidence to prevent bias and protect patient safety.

Key Regional Insights for Contrast Media

Asia-Pacific is a major demand engine because it combines large population scale, expanding hospital infrastructure, rising CT and MRI access, and growing use of image-guided care across China, India, Japan, South Korea, Australia, and Southeast Asia. UN population data confirms that the region contains the majority of the global population, creating structural need for diagnostic imaging as cancer, cardiovascular disease, diabetes, renal disease, and age-related disorders increase.

North America remains a high-value environment due to advanced radiology networks, FDA-regulated product innovation, broad CT and MRI utilization, and strong adoption of interventional radiology. Europe is shaped by EMA oversight, the EU Medical Device Regulation, ESUR safety guidance, pharmacovigilance discipline, and healthcare sustainability expectations. Latin America is expanding access through public and private hospital investment, especially in urban diagnostic centers, while the Middle East is accelerating imaging modernization through national health strategies and specialty care investments. Africa shows long-term potential as countries improve diagnostic capacity, although WHO and IAEA assessments continue to highlight uneven access to advanced imaging equipment, radiologists, technologists, and reliable medical supply chains.

Key Group Insights Across Economic and Policy Blocs

ASEAN demand is supported by urbanization, medical tourism, noncommunicable disease screening, and public investment in tertiary hospitals, particularly across Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is advancing premium diagnostic imaging capacity through national transformation programs, specialized hospitals, and complex tertiary care pathways, reinforcing demand for high-reliability contrast supply, injector systems, and protocol governance.

The European Union emphasizes clinical safety, pharmacovigilance, sustainability, regulatory compliance, and cross-border evidence standards, making evidence-based product differentiation essential. BRICS markets combine large patient pools with expanding hospital infrastructure, local manufacturing ambitions, and cost-sensitive procurement. G7 countries lead in premium imaging, clinical guideline adoption, digital radiology infrastructure, and AI-enabled workflow development. NATO markets benefit from mature hospital systems, emergency preparedness, and defense-related trauma readiness, where rapid vascular assessment, CT angiography, and interventional imaging remain clinically important.

Key Country Insights for Contrast Media Demand

The United States is a leading value opportunity due to high CT and MRI utilization, advanced interventional radiology, FDA-cleared innovation, oncology imaging intensity, and widespread use of automated contrast injectors. Canada emphasizes safety, procurement efficiency, and equitable access across provincial health systems, while Mexico and Brazil are expanding private hospital networks, advanced diagnostic centers, and imaging access in large metropolitan areas.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show strong demand tied to oncology, cardiovascular imaging, emergency care, and aging populations, while Russia maintains demand through large hospital systems despite supply-chain complexity. China and India are scale-driven opportunities as imaging capacity expands and chronic disease diagnosis increases. Japan and South Korea lead in advanced modalities, quality standards, and high-throughput radiology operations, while Australia combines strong clinical governance with broad access to modern radiology services and structured safety protocols.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence-backed safety, supply resilience, and protocol-level value rather than competing solely on price. Manufacturers can strengthen differentiation through macrocyclic MRI agents, low-osmolar and iso-osmolar iodine portfolios, microbubble ultrasound applications, renal-risk management support, and packaging that reduces waste and supports automated contrast management.

Providers should standardize contrast protocols, integrate renal-risk screening, document allergy and hypersensitivity history, train staff on extravasation and emergency response, and use injector analytics to optimize dose and reduce waste. Commercial teams should align with hospital procurement goals by documenting total cost of ownership, availability performance, clinical education, product traceability, and compliance with ACR, ESUR, FDA, EMA, and local pharmacovigilance requirements.

Research Methodology

This executive summary is developed using a structured secondary and primary research approach consistent with market intelligence best practices. Inputs include regulatory databases, clinical guidelines, peer-reviewed radiology literature, public health statistics, hospital procurement indicators, product approvals, pharmacovigilance updates, supply-chain observations, and expert perspectives from healthcare and imaging stakeholders.

Findings are triangulated across demand drivers, modality trends, regional healthcare investment, clinical safety considerations, competitive positioning, and expert validation. The methodology emphasizes data integrity, source verification, and practical market interpretation so stakeholders can evaluate contrast media opportunities by product class, imaging modality, end user, region, group, and country while avoiding unsupported sizing or forecasting claims.

Conclusion

The contrast media market is moving into a more disciplined, technology-enabled phase where safety, access, and workflow efficiency define competitive advantage. Rising diagnostic imaging use, aging populations, cancer and cardiovascular disease burden, renal-risk awareness, and expanding interventional procedures continue to support durable clinical relevance.

Future leadership will depend on resilient supply chains, clinically differentiated formulations, AI-enabled imaging operations, and compliance with evolving regulatory, pharmacovigilance, and sustainability expectations. Organizations that combine product reliability with clinical education, digital workflow support, and regional adaptation are best positioned to strengthen performance in contrast-enhanced imaging.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Contrast Media Market, by Product Type
7.1. Introduction
7.2. Barium-based Contrast Media
7.3. Gadolinium-based Contrast Media
7.4. Iodinated Contrast Media
7.5. Microbubble Contrast Media
8. Contrast Media Market, by Imaging Modality
8.1. Introduction
8.2. Computed Tomography (CT)
8.3. Magnetic Resonance Imaging (MRI)
8.4. Optical Imaging
8.5. Ultrasound
8.6. X-Ray & Fluoroscopy
9. Contrast Media Market, by Form
9.1. Introduction
9.2. Liquid
9.3. Paste
9.4. Powder
10. Contrast Media Market, by Route of Administration
10.1. Introduction
10.2. Intravascular Route
10.3. Oral Route
10.4. Rectal Route
11. Contrast Media Market, by Application
11.1. Introduction
11.2. Cancer
11.3. Cardiovascular Diseases
11.4. Gastrointestinal Disorders
11.5. Musculoskeletal Disorders
11.6. Nephrological Disorders
11.7. Neurological Disorders
12. Contrast Media Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Diagnostic Imaging Centers
12.4. Hospitals
13. Contrast Media Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Contrast Media Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Contrast Media Market, by Country
15.1. United States
15.2. Germany
15.3. China
15.4. United Kingdom
15.5. India
15.6. Japan
15.7. Russia
15.8. Brazil
15.9. Canada
15.10. Italy
15.11. Mexico
15.12. France
15.13. Spain
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Acro Lifesciences (I) Pvt. Ltd.
17.2. APOLLO RT Co. Ltd.
17.3. Bayer AG
17.4. Beijing Beilu Pharmaceutical Co., Ltd.
17.5. Bracco Spa
17.6. Daiichi Sankyo Co. Ltd.
17.7. Eskay Iodine Pvt. Ltd.
17.8. Fuji Pharma Co. Ltd.
17.9. GE Healthcare
17.10. Guerbet SA
17.11. J. B. Chemicals & Pharmaceuticals Limited
17.12. Jodas Expoim Pvt. Ltd.
17.13. Lantheus Medical Imaging, Inc.
17.14. Livealth Biopharma
17.15. M.Biotech Limited
17.16. Maya Biotech
17.17. MEDTRON AG
17.18. nanoPET Pharma GmbH
17.19. Novalek Pharmaceuticals Pvt Ltd.
17.20. Rege Imaging & Cine Films (P) Ltd.
17.21. SANOCHEMIA Pharmazeutika GmbH
17.22. Spago Nanomedical AB
17.23. Trivitron Healthcare
17.24. ulrich GmbH & Co. KG
17.25. Unijules Life Sciences Limited
17.26. Vitalquan, LLC
17.27. Zhejiang Starry Pharmaceutical Co., Ltd.
List of Figures
FIGURE 1. GLOBAL CONTRAST MEDIA MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CONTRAST MEDIA MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CONTRAST MEDIA MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CONTRAST MEDIA MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CONTRAST MEDIA MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CONTRAST MEDIA MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL IODINATED CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL IODINATED CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL IODINATED CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL COMPUTED TOMOGRAPHY (CT) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL OPTICAL IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL X-RAY & FLUOROSCOPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL X-RAY & FLUOROSCOPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL X-RAY & FLUOROSCOPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PASTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PASTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PASTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INTRAVASCULAR ROUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL INTRAVASCULAR ROUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL INTRAVASCULAR ROUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ORAL ROUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ORAL ROUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ORAL ROUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL RECTAL ROUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL RECTAL ROUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL RECTAL ROUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MUSCULOSKELETAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL NEPHROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL NEPHROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL NEPHROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DIAGNOSTIC IMAGING CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. EUROPE CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. EUROPE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 105. EUROPE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 106. EUROPE CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 107. EUROPE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 108. EUROPE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. EUROPE CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. AFRICA CONTRAST MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. AFRICA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 119. AFRICA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 120. AFRICA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 121. AFRICA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 122. AFRICA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. AFRICA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. ASEAN CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. ASEAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. ASEAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 128. ASEAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 129. ASEAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 130. ASEAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. ASEAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. GCC CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GCC CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 134. GCC CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 135. GCC CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 136. GCC CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 137. GCC CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. GCC CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. BRICS CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. BRICS CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 148. BRICS CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 149. BRICS CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 150. BRICS CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 151. BRICS CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. BRICS CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. G7 CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. G7 CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 155. G7 CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 156. G7 CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 157. G7 CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 158. G7 CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. G7 CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 160. NATO CONTRAST MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. NATO CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 162. NATO CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 163. NATO CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 164. NATO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 165. NATO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. NATO CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL CONTRAST MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 168. UNITED STATES CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 169. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 170. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 171. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 172. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 173. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 174. UNITED STATES CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. GERMANY CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 176. GERMANY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. GERMANY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 178. GERMANY CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 179. GERMANY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 180. GERMANY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. GERMANY CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. CHINA CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. CHINA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. CHINA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 185. CHINA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 186. CHINA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 187. CHINA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. CHINA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 189. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 190. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 192. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 193. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 194. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. UNITED KINGDOM CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. INDIA CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 197. INDIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. INDIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 199. INDIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 200. INDIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 201. INDIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. INDIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. JAPAN CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. JAPAN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 205. JAPAN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 206. JAPAN CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 207. JAPAN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 208. JAPAN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. JAPAN CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. RUSSIA CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 211. RUSSIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. RUSSIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 213. RUSSIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 214. RUSSIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 215. RUSSIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 216. RUSSIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. BRAZIL CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. BRAZIL CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 224. CANADA CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. CANADA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. CANADA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 227. CANADA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 228. CANADA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 229. CANADA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. CANADA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. ITALY CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. ITALY CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 233. ITALY CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 234. ITALY CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 235. ITALY CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 236. ITALY CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. ITALY CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. MEXICO CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. MEXICO CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 240. MEXICO CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 241. MEXICO CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 242. MEXICO CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 243. MEXICO CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. MEXICO CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. FRANCE CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. FRANCE CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. FRANCE CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 248. FRANCE CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 249. FRANCE CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 250. FRANCE CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 251. FRANCE CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. SPAIN CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. SPAIN CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 254. SPAIN CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 255. SPAIN CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 256. SPAIN CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 257. SPAIN CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 258. SPAIN CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. AUSTRALIA CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 260. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 261. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 262. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 263. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 264. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 265. AUSTRALIA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY IMAGING MODALITY, 2017-2032 (USD MILLION)
TABLE 269. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY FORM, 2017-2032 (USD MILLION)
TABLE 270. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 271. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. SOUTH KOREA CONTRAST MEDIA MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 273. GLOBAL CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2025
TABLE 274. GLOBAL CONTRAST MEDIA MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Acro Lifesciences (I) Pvt. Ltd.
  • APOLLO RT Co. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Spa
  • Daiichi Sankyo Co. Ltd.
  • Eskay Iodine Pvt. Ltd.
  • Fuji Pharma Co. Ltd.
  • GE Healthcare
  • Guerbet SA
  • J. B. Chemicals & Pharmaceuticals Limited
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • Livealth Biopharma
  • M.Biotech Limited
  • Maya Biotech
  • MEDTRON AG
  • nanoPET Pharma GmbH
  • Novalek Pharmaceuticals Pvt Ltd.
  • Rege Imaging & Cine Films (P) Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • ulrich GmbH & Co. KG
  • Unijules Life Sciences Limited
  • Vitalquan, LLC
  • Zhejiang Starry Pharmaceutical Co., Ltd.

Table Information